Continuous proton pump inhibitor treatment decreases upper gastrointestinal bleeding and related death in rural area in Japan

Journal of Gastroenterology and Hepatology (Australia)

Volumn 27, Issue 2, 2012, Pages 372-377

  Miyamoto, Masaki ^a   Haruma, Ken ^b   Okamoto, Takeshi ^a   Higashi, Yuusuke ^c   Hidaka, Toru ^c   Manabe, Noriaki ^b  

^a Hiroshima Prefecture Hiroshima Hospital   (Japan)

^b KAWASAKI MEDICAL SCHOOL   (Japan)

^c Department of Internal Medicine   (Japan)

Author keywords

Aspirin; Incidence; Non steroidal anti inflammatory drugs (NSAIDs); Proton pump inhibitors; Upper gastrointestinal bleeding

Indexed keywords

ACETYLSALICYLIC ACID; HISTAMINE H2 RECEPTOR ANTAGONIST; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; CORRELATIONAL STUDY; DRUG UTILIZATION; FEMALE; GERIATRIC DISORDER; HUMAN; INCIDENCE; JAPAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; OUTCOME ASSESSMENT; POPULATION RESEARCH; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RURAL AREA; UPPER GASTROINTESTINAL BLEEDING;

EID: 84856186380     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2011.06878.x     Document Type: Article

References (33)

1. Vreeburg EM, Snel P, de Brujine JW, Bartelsman JF, Rauws EA, Tygat GN. Acute upper gastrointestinal bleeding in the Amsterdam area: incidence, diagnosis, and clinical outcome. Am. J. Gastroenterol. 1997; 92: 236-43.
2. Gilbert DA. Epidemiology of upper gastrointestinal bleeding. Gastrointest. Endosc. 1990; 36: S8-13.
3. Laperfido S, Baldo V, Piovesana E etal. Changing trends in acute upper-GI bleeding: a population-based study. Gastrointest. Endosc. 2009; 70: 212-24.
4. Asaki S. Hematomesis and melena (review). Rinsyo Syokaki Naika 1988; 3: 511-7. (in Japanese).
5. Peres-Aisa MA, Del Pino D, Siles M, Lanas A. Clinical trends in upper diagnosis in a population with high prevalence of Helicobacter pylori infection. Aliment. Pharmacol. Ther. 2005; 21: 65-72.
6. Zullo A, Hassan C, Campo SM, Morini S. Bleeding peptic ulcer in the elderly: risk factors and prevention strategies. Drugs Aging 2007; 24: 815-28.
7. Hermansson M, Ekedahl A, Ranstam J, Zilling TD. Decreasing incidence of peptic ulcer complications after the introduction of the proton pump inhibitors, a study of the Swedish population from 1974-2002. BMJ Gastroenterol. 2009 20: 9-25.
8. Ministry of Health, Labour and Welfare of Japan. Cited 27 August 2011. Available from URL:.
9. Ootani H, Iwakiri R, Shimoda R etal. Role of Helicobacter pylori infection and nonsteroidal anti-inflammatory drug use in bleeding peptic ulcers in Japan. J. Gastroenterol. 2006; 41: 41-6.
10. Chan HL, Wu JC, Chan FK etal. Is non-Helicobacter pylori, non-NSAID peptic ulcer a common cause of upper gastrointestinal bleeding? A prospective study of 977 patients. Gastrointest. Endosc. 2001; 53: 438-42.
11. Kikkawa A, Iwakiri R, Ootani H etal. Prevention of rehaemorrhage of bleeding peptic ulcers: effects of Helicobacter pylori eradication and acid suppression. Aliment. Pharmacol. Ther. 2005; 21: 79-84.
12. de Leest HT, Steen KS, Lems WF etal. Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment in double-blind, randomized, placebo-controlled trial. Helicobacter. 2007; 12: 477-85.
13. Vergara M, Catalan M, Gisbert JP etal. Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users. Aliment. Pharmacol. Ther. 2005; 21: 1411-8.
14. Asaka M, Kimura T, Kudo M etal. Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology. 1992; 102: 760-6.
15. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002; 324: 71-86.
16. Taha AS, Angerson WJ, Knill-Jones RP, Blatchford O. Upper gastrointestinal haemorrhage associated with low-dose aspirin and anti-thrombotic drugs-a 6-year analysis and comparison with non-steroidal ant-inflammatory drugs. Aliment. Pharmacol. Ther. 2005; 22: 285-9.
17. Sakamoto C, Sugano K, Ota S etal. Case-control study on the association of upper gastrointestinal bleeding and nonsteroidal anti-inflammatory drugs in Japan. Eur. J. Clin. Pharmacol. 2006; 62: 765-72.
18. Hallas J, Dall M, Andries A etal. Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study. BMJ. 2006; 333: 726.
19. Derry S, Loke YK. Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis. BMJ 2000; 321: 1183-7.
20. Lanas A, Scheiman J. Low-dose aspirin and upper gastrointestinal damage: epidemiology, prevention and treatment. Curr. Med. Res. Opin. 2007; 23: 163-73.
21. Nakayama M, Iwakiri R, Hara M etal. Low-dose aspirin is a prominent cause of bleeding ulcers in patients who underwent emergency endoscopy. J. Gastroenterol. 2009; 44: 912-8.
22. Scheiman JM, Fedrick AM. Practical approaches to minimizing gastrointestinal and cardiovascular safety concerns with COX-2 inhibitors and NSAIDs. Arthritis Res. Ther. 2005; 7: S23-29. (review).
23. Strand V. Are COX-2 inhibitors preferable to non-selective non-steroidal anti-inflammatory drugs in patients with risk of cardiovascular events taking low-dose aspirin? Lancet 2007; 370: 2138-51.
24. Rostom A, Dube C, Wells G etal. Prevention of NSAIDs-induced upper gastrointestinal toxicity. Cochrane Database Syst. Rev. 2002; 4: CD002296.
25. Leontiadis GI, Sreedharan A, Dorward S etal. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding. Health Technol. Assess. 2007; 11: 1-164.
26. Hata M, Shiono M, Sekine H etal. Prospective randomized trial for optimal prophylactic treatment of upper gastrointestinal complications after open heart surgery. Circ. J. 2005; 69: 331-4.
27. Chin MWS, Yong G, Bulsara MK, Rankin J, Forbes GM. Predictive and protective factors associated with upper gastrointestinal bleeding after percutaneous coronary intervention: a case-control study. Am. J. Gastroenterol. 2007; 102: 2411-6.
28. Lai KC, Lam SK, Chu KM etal. Lansoprazole for prevention of recurrences of ulcer complications from long-term low-dose aspirin use. N. Engl. J. Med. 2002; 346: 2033-8.
29. Ibanez L, Vidal X, Vendrell L, Moretti U, Laporte JR. Spanish-Italian Collaborative Group for the Epidemiology of Gastrointestinal Bleeding. Upper gastrointestinal bleeding associated with antiplatelet drugs. Aliment. Pharmacol. Ther. 2006; 23: 235-42.
30. Lanas A, Garcia-Rodriguez LA, Arroyo MT etal. Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants. Am. J. Gastroenterol. 2007; 102: 507-15.
31. Pillotto A, Franceschi M, Leandro G etal. Proton-pump inhibitors reduced the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs. Aliment. Pharmacol. Ther. 2004; 20: 1091-9.
32. Bhatt DL, Scheiman J, Abraham NS etal. ACCF/ACC/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. Am. J. Gastroenterol. 2008; 103: 2890-907.
33. Arakawa T, Fujiwara Y, Sollano J etal. Situation in prescription of nonsteroidal anti-inflammatory drugs and aspirin in 2007 in Asian countries: survey with questionnaire for specialists and general physicians. Digestion 2009; 79: 117-85.